## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-20T04:17:36.491Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "GLP-1 Tracker: Pep" developer_entity: "Shred Apps, LLC" bundle_id: "com.shredapps.glp1" app_store_id: "6504788281" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-05-14" report_date: "2026-05-20" last_verified: "2026-05-20" report_version: "2.0.4" total_reviews: 2257 overall_rating: 4.64 sentiment: "Mixed" sentiment_score: 55 confidence: "low" confidence_score: 0.9 top_praise_theme: "Comprehensive tracking of GLP-1 medication and progress metrics keeps users focused on their health goals" top_complaint_theme: "Inaccurate AI meal calorie estimation poses potential health risks for users tracking weight loss" top_request_theme: "Integration with wearable devices to automatically sync activity and biometric data" review_sample_size: 112 total_review_count: 112 analyzed_review_count: 64 data_age_days: 0 momentum_velocity: "active" intelligence_version: 3 nemesis: "Medisafe Medication Management" competitor_count: 8 tags: ["medical", "freemium", "mixed sentiment", "mobile app", "app review", "app analysis", "individuals", "prescribed", "glp-1"] canonical_url: "https://marlvel.ai/intel-report/medical/com-shredapps-glp1" license: "CC-BY-NC 4.0" content_version: "v2" --- # GLP-1 Tracker: Pep App Audit ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.64 · Sentiment Mixed - **Recent focus**: Inaccurate AI meal calorie estimation poses potential health risks for users tracking weight loss (top complaint) · Comprehensive tracking of GLP-1 medication and progress metrics keeps users focused on their health goals (top praise) · Integration with wearable devices to automatically sync activity and biometric data (top request) > **TL;DR:** GLP-1 Tracker: Pep is a medical app by Shred Apps, LLC, rated 4.64/5 by 2.3K users, with Mixed user sentiment (55/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** GLP-1 Tracker: Pep shows Mixed sentiment (4.64/5 from 2.3K reviews) — users praise comprehensive tracking of glp-1 medication and progress metrics keeps users focused on their health goals but report issues with inaccurate ai meal calorie estimation poses potential health risks for users tracking weight loss. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.64/5 (2.3K reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | Shred Apps, LLC | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | Low (0.9/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Shred Apps, LLC - **Category:** Medical - **Target Audience:** Individuals prescribed GLP-1 medications for weight loss who require a centralized tool for medication adherence, nutrition tracking, and progress monitoring. - **Platforms:** iOS & Android - **Version Audited:** 2.0.4 - **Audit Date:** 2026-05-20 - **Signal Count:** 112 reviews analyzed - **Confidence:** Low (0.9/1.0) - **App Store ID (iOS):** 6504788281 - **Bundle ID:** com.shredapps.glp1 - **Google Play ID:** com.shredapps.glp1 - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-20 - **Short Description:** GLP-1 shot tracker reminders: Ozempic, Mounjaro, Wegovy, Zepbound, Compound GLP1 ## Executive Snapshot **What it is:** Pep is a medical tracking app for GLP-1 medication users, providing injection reminders, nutrition logging, and progress visualization on iOS and Android. **Why users hire it:** Users hire Pep to manage the high-stakes, multi-step requirements of GLP-1 treatment in one place, reducing the cognitive load of tracking medication, side effects, and nutrition simultaneously. ## App DNA (Features & Intent) - **[Standard] GLP-1 Medication Tracker:** Logs injectable and oral medication doses including Ozempic, Wegovy, Mounjaro, and Zepbound * *User Intent:* Users want visibility into their own performance and progress. - **[Differentiator] AI Food Scanner:** Uses photo and barcode recognition to estimate calories, protein, and fiber via FatSecret API * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Injection Site Rotation Tracking:** Prompts users to alternate injection locations to prevent tissue damage * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Pep currently holds a #64 Grossing position in the US Medical category. The gap between its utility-driven free user base and its grossing rank indicates that the premium gate for AI nutrition features is not yet converting at scale. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free version with core tracking features, Premium membership for advanced tracking and insights - **Analysis:** Freemium model uses a free-to-download entry point with a premium gate for advanced nutrition and progress analytics. ## 🟡 User Sentiment (Low Confidence: 64 of 112 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.64/5 - **Platform Split:** iOS 4.7/5 (756 ratings) | Android 4.6/5 (1.5K ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Comprehensive tracking of GLP-1 medication and progress metrics keeps users focused on their health goals** ### Top Complaints (Impact Areas) - **Inaccurate AI meal calorie estimation poses potential health risks for users tracking weight loss** ### Top Requests (What Users Want) - **Integration with wearable devices to automatically sync activity and biometric data** ## SWOT Analysis {#swot} **Core Strengths:** - Centralized GLP-1-specific workflow reduces user cognitive load - Injection site rotation tracking creates specialized health-safety switching costs **Critical Frictions:** - AI meal scanner calorie variance poses health-safety risks - Billing friction causes unauthorized charges - Technical regressions in dosage logging erode trust **Growth Levers:** - Integration with wearable devices would automate biometric data - Expansion into professional-grade PDF reporting for endocrinologists **Market Threats:** - Telehealth-integrated platforms like Hims capture the entire value chain - Hardware-tethered apps like Libre by Abbott create high barriers to entry ## Recent Changes (v2 → v3) {#recent-changes} The app expanded its medication support to include oral pills but faces declining user sentiment due to technical instability, billing friction, and inaccurate AI meal logging. **Overall trend**: Declining **Compared at**: 2026-05-20 ### High-impact changes - **[Declined] Sentiment and Confidence Downgrade** (sentiment) — Overall sentiment moved from positive to mixed, with the sentiment score falling from 68 to 55 and confidence dropping from high to low. - **[Added] New Critical Weaknesses** (swot) — SWOT analysis now includes technical regressions in dosage logging and billing friction causing unauthorized charges. ### Medium-impact changes - **[Added] Oral GLP-1 Medication Support** (features) — Expanded tracking capabilities to include oral GLP-1 pills alongside injectable medications. - **[Shifted] Executive Summary Tone** (positioning) — Positioning shifted from 'all-in-one companion' to a warning that the product is scaling faster than its core infrastructure can support. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### GLP-1 Tracker: Pep vs Medisafe Medication Management — Head to Head - **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by MediSafe Inc.: Directly competes on the core job-to-be-done of medication adherence and complex reminder scheduling for chronic conditions. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Integrates comprehensive drug-to-drug interaction warnings that go beyond simple shot reminders - Supports family caregiver accounts allowing multiple users to manage a single patient's medication schedule ### Contenders (Strong Challengers) - **[Glucose Buddy Diabetes Tracker](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy)** by Azumio Inc. [Moat: Medium]: Targets the exact same metabolic health audience with a focus on logging blood glucose and weight trends. - Provides deep integration with external glucose monitoring hardware for automated data syncing - Offers a long-standing community forum for peer support which increases user stickiness - **[mySugr - Diabetes Tracker Log](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr)** by mySugr GmbH [Moat: High]: Dominates the diabetes logging space with a gamified UX that directly challenges the 'Pep' engagement model. - Utilizes gamification mechanics like challenges and point systems to drive daily logging consistency - Provides professional-grade PDF reports specifically formatted for endocrinologist consultations ### Peers (What They Do Better) - **[GoodRx: Prescription Savings](https://marlvel.ai/intel-report/medical/com-goodrx-iphone)** by GoodRx: Adjacent utility that captures the same user base seeking to manage the high costs of GLP-1 medications. - Provides real-time pharmacy pricing comparisons that directly influence medication acquisition decisions - Offers a massive distribution network integrated into the pharmacy checkout experience - **[Hims: Telehealth for Men](https://marlvel.ai/intel-report/medical/com-himshers-ios)** by Hims & Hers: Represents the vertical integration of telehealth and prescription fulfillment which is the ultimate destination for GLP-1 users. - Controls the entire value chain from initial provider consultation to direct-to-consumer medication delivery - Aggressive brand positioning focused on lifestyle and aesthetic outcomes rather than just medical tracking - **[Libre by Abbott](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us)** by Abbott Labs: Hardware-tethered ecosystem that creates a high barrier to entry for independent tracking apps. - Proprietary data stream from continuous glucose monitors provides clinical-grade accuracy for users - Locked-in ecosystem ensures users remain within the Abbott digital environment for all health data ### New Kids on the Block (What's Innovative) - **[athenaPatient](https://marlvel.ai/intel-report/medical/com-athenahealth-athenapatient)** by athenahealth: Rapidly expanding patient portal with 5 releases in 6 months, signaling a push into mobile-first patient engagement. - **[Spruce: Medical Communication](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live)** by Spruce Health: High-velocity updates (12 releases in 6 months) indicate a focus on professional-grade patient-provider communication. ## What's New - **Latest (v2.0.4, 6 days ago):** Added support for oral GLP-1 pills alongside injections and improved the logging user experience. ## App Momentum (Active) {#momentum} - Added support for oral GLP-1 pills. - Shipped performance optimizations for logging. > **Cadence:** 5 total versions · 2 majors in last 6 months · 6 days since last update · 15 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} GLP-1 Tracker: Pep is an established medical app that is free with in-app purchases. With a 4.64/5 rating from 2.3K reviews, it shows polarized user reception. > **Bottom Line:** Pep succeeds by centralizing GLP-1 adherence, but technical instability and AI inaccuracy threaten its retention, so the PM must prioritize core data reliability over new feature expansion to stabilize the user base. **Best for:** Individuals prescribed GLP-1 medications for weight loss who require a centralized tool for medication adherence, nutrition tracking, and progress monitoring. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] [HIGH IMPACT] Ship manual override for AI food scanner — *AI calorie inaccuracy is a top complaint, threatening user health-safety trust.* _(trade-off: deprioritize Pause the wearable integration sprint to prioritize core data accuracy.)_ - [ ] [MAINTAIN] [HIGH IMPACT] Audit billing and cancellation flows — *Unauthorized charge reports are rising, creating significant brand drag.* _(trade-off: deprioritize Same-quarter capacity available — no major lever displaced.)_ ### Feature Gaps vs Competitors - Clinical-grade drug-to-drug interaction warnings (available in Medisafe) - Family caregiver accounts (available in Medisafe) - Direct EHR integration (available in athenaPatient) ### Outlook: Mixed The GLP-1 tracking market is consolidating around tools that offer clinical-grade reliability, leaving Pep exposed to churn if its AI-driven features continue to underperform. The PM must pivot from feature-heavy updates to stability-first engineering to prevent users from migrating to more established medical-management platforms. - 🔴 Technical regressions in the latest update break dosage logging, which directly erodes the daily habit and increases churn risk. - ⚪ Recent updates focused on stability and oral pill support, indicating a shift toward maintaining core utility over aggressive feature expansion. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.64/5 | | Total Reviews | 2.3K | | Sentiment | Mixed (55/100) | | Confidence | Low | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **GLP-1 Tracker: Pep** (this app) | 4.64/5 | Mixed | Shred Apps, LLC | | [Libre by Abbott](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us) | 4.6/5 | N/A | Abbott Labs | | [GoodRx: Prescription Savings](https://marlvel.ai/intel-report/medical/com-goodrx-iphone) | 4.8/5 | Thrilled | GoodRx | | [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | Upset | MediSafe Inc. | | [Spruce: Medical Communication](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live) | 4.9/5 | N/A | Spruce Health | | [Hims: Telehealth for Men](https://marlvel.ai/intel-report/medical/com-himshers-ios) | 4.8/5 | N/A | Hims & Hers | ## Company Profile - **Developer:** Shred Apps, LLC - **Website:** [https://pepglp1.com/](https://pepglp1.com/) - **Social:** [Instagram](https://www.instagram.com/pepglpapp) · [YouTube](https://www.youtube.com/channel/UCtHRP6OecoPt7JE5tP1ESqQ) · [TikTok](https://www.tiktok.com/@pep.glp1.tracker) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/glp-1-tracker-pep/id6504788281?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.shredapps.glp1&hl=en&gl=us) - **Dev Site:** [Official Website](https://pepglp1.com/) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Libre by Abbott*](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us) (Abbott Labs) — 4.6/5 Rating | N/A Sentiment - [*GoodRx: Prescription Savings*](https://marlvel.ai/intel-report/medical/com-goodrx-iphone) (GoodRx) — 4.8/5 Rating | Excellent Sentiment - [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) — 4.7/5 Rating | Terrible Sentiment - [*Spruce: Medical Communication*](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live) (Spruce Health) — 4.9/5 Rating | N/A Sentiment - [*Hims: Telehealth for Men*](https://marlvel.ai/intel-report/medical/com-himshers-ios) (Hims & Hers) — 4.8/5 Rating | N/A Sentiment - [*Glucose Buddy Diabetes Tracker*](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy) (Azumio Inc.) — 4.8/5 Rating | Terrible Sentiment - [*athenaPatient*](https://marlvel.ai/intel-report/medical/com-athenahealth-athenapatient) (athenahealth) — 4.9/5 Rating | N/A Sentiment - [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr) (mySugr GmbH) — 4.7/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.9/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 112 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-shredapps-glp1) Data licensed for AI Agent attribution under CC-BY-NC 4.0.